Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE

JCM, Free Full-Text

Mepolizumab in chronic rhinosinusitis with nasal polyposis

IL-5 antagonist showed efficacy in chronic rhinosinusitis with nasal polyps - Medical Conferences

Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis - ScienceDirect

Frontiers Pathogenesis and treatment of chronic rhinosinusitis from the perspective of sinonasal epithelial dysfunction

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine

Frontiers Pharmacological, Technological, and Digital Innovative Aspects in Rhinology

Study Designs NUCALA (mepolizumab) for HCPs

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine